Abstract: A method for producing a graphene oxide-based compound for an air electrode of a metal-air battery. A nitrogen and sulfur-based organic compound is added to an aqueous suspension of a graphene oxide. The water of the suspension is evaporated in order to obtain a powder. This powder is heated under an inert atmosphere in order to sublime the organic compound and stimulate the incorporation of nitrogen from the organic compound into the graphitic sites of the graphene oxide. The nitrogen and sulfur-doped graphene oxide is added to a second aqueous suspension comprising a cobalt nitrate-based compound. This second suspension is heated in order to form nanoparticles of cobalt oxide at the surface of at least one nitrogen and sulfur-doped graphene oxide sheet.

Abstract: A method for producing a graphene oxide-based compound for an air electrode of a metal-air battery. A nitrogen and sulfur-based organic compound is added to an aqueous suspension of a graphene oxide. The water of the suspension is evaporated in order to obtain a powder. This powder is heated under an inert atmosphere in order to sublime the organic compound and stimulate the incorporation of nitrogen from the organic compound into the graphitic sites of the graphene oxide. The nitrogen and sulfur-doped graphene oxide is added to a second aqueous suspension comprising a cobalt nitrate-based compound. This second suspension is heated in order to form nanoparticles of cobalt oxide at the surface of at least one nitrogen and sulfur-doped graphene oxide sheet.

Abstract: The invention relates to using persistent luminescence nanoparticles, functionalised if necessary, in the form of an diagnosis agent for an in vivo optical imaging. Said nanoparticles are preferably consist of a compound selected from a group comprising (1) silicates, aluminates, aluminosilicates, germanates, titanates, oxysulphides, phosphates and vanadates, wherein said compounds contain at least one type of metal oxide, (2) the sulphides comprise at least one metal ion selected from zinc, strontium and calcium, and (3) metal oxides, wherein said compounds is doped with at least one rare earth ion, and possibly with at least one transition metal ion. In a preferred embodiment, the diagnosis agent is used for an organism vascularization imaging. A method and kit for detecting or quantifying in vitro a substance of biological or chemical interest in a sample by using said pre-functionalised nanoparticles are also disclosed.

Abstract: The subject of the invention is a method for obtaining particles of chemical formula BiVO4 wherein bismuth and vanadium precursors and at least one additive chosen from surfactants of the sulphate or phosphonate type comprising at least one hydrocarbon chain are made to react at a temperature below 50° C. The subject of the invention is also particles of chemical formula BiVO4 of which the surface has Brønsted sites.

Abstract: The invention relates to an optical fiber comprising a gain medium which is equipped with: a core (22) which is formed from a transparent material and nanoparticles (24) comprising a doping element and at least one element for enhancing the use of said doping element; and an outer cladding (26) which surrounds the core. The invention is characterized in that the doping element is erbium (Er) and in that the enhancing element is selected from among antimony (Sb), bismuth (Bi) and a combination of antimony (Sb) and bismuth (Bi). According to the invention, one such fiber is characterized in that the size of the nanoparticles is variable and is between 1 and 500 nanometers inclusive, and preferably greater than 20 nm.

Abstract: The invention relates to an optical fiber comprising a gain medium which is equipped with: a core (22) which is formed from a transparent material and nanoparticles (24) comprising a doping element and at least one element for enhancing the use of said doping element; and an outer cladding (26) which surrounds the core. The invention is characterised in that the doping element is erbium (Er) and in that the enhancing element is selected from among antimony (Sb), bismuth (Bi) and a combination of antimony (Sb) and bismuth (Bi). According to the invention, one such fiber is characterised in that the size of the nanoparticles is variable and is between 1 and 500 nanometers inclusive, and preferably greater than 20 nm.

Abstract: The invention relates to an optical fibre comprising a gain medium which is equipped with: a core (22) which is formed from a transparent material and nanoparticles (24) comprising a doping element and at least one element for enhancing the use of said doping element; and an outer cladding (26) which surrounds the core. The invention is characterised in that the doping element is erbium (Er) and in that the enhancing element is selected from among antimony (Sb), bismuth (Bi) and a combination of antimony (Sb) and bismuth (Bi). According to the invention, one such fibre is characterised in that the size of the nanoparticles is variable and is between 1 and 500 nanometres inclusive, and preferably greater than 20 nm.

Abstract: The invention relates to using persistent luminescence nanoparticles, functionalised if necessary, in the form of an diagnosis agent for an in vivo optical imaging. Said nanoparticles are preferably consist of a compound selected from a group comprising (1) silicates, aluminates, aluminosilicates, germanates, titanates, oxysulphides, phosphates and vanadates, wherein said compounds contain at least one type of metal oxide, (2) the sulphides comprise at least one metal ion selected from zinc, strontium and calcium, and (3) metal oxides, wherein said compounds is doped with at least one rare earth ion, and possibly with at least one transition metal ion. In a preferred embodiment, the diagnosis agent is used for an organism vascularisation imaging. A method and kit for detecting or quantifying in vitro a substance of biological or chemical interest in a sample by using said pre-functionalised nanoparticles are also disclosed.

Abstract: The invention relates to an optical fibre comprising a gain medium which is equipped with: a core (22) which is formed from a transparent material and nanoparticles (24) comprising a doping element and at least one element for enhancing the use of said doping element; and an outer cladding (26) which surrounds the core. The invention is characterised in that the doping element is erbium (Er) and in that the enhancing element is selected from among antimony (Sb), bismuth (Bi) and a combination of antimony (Sb) and bismuth (Bi). According to the invention, one such fibre is characterised in that the size of the nanoparticles is variable and is between 1 and 500 nanometres inclusive, and preferably greater than 20 nm.